July 28th, 2022 | 🕒
iSpeech Three-Year Follow Up Results Confirm Significant Efficacy and No Serious Adverse Effects in Patients receiving OvaStem® Procedure for Treating
June 15th, 2022 | 🕒
TTS Demo PHOENIX, June 15, 2022 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ:
April 30th, 2022 | 🕒
iSpeech.org PHOENIX, April 29, 2022 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a
March 31st, 2022 | 🕒
dutch tts PHOENIX, March 31, 2022 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ:
March 23rd, 2022 | 🕒
iSpeech.org --Two-Year Follow-Up Results Confirm Significant Efficacy and No Serious Adverse Effects in Patients Using StemSpine® Procedure for Treating Chronic Lower
June 9th, 2021 | 🕒
iSpeech PHOENIX, June 9, 2021 /PRNewswire/ -- Creative Medical Technology Holdings, trading under Ticker Symbol CELZ, announced the filing of a
March 4th, 2021 | 🕒
TTS PHOENIX, March 4, 2021 /PRNewswire/ -- (OTC - CELZ) Creative Medical Technology Holdings announced today a publication in the pre-print server
March 3rd, 2021 | 🕒
iSpeech PHOENIX, March 3, 2021 /PRNewswire/ -- (OTC-CELZ) Creative Medical Technology Holdings announced today that due to COVID related technical
Gloss